Ind-Swift Laboratories Limited Cash Flow Conversion Efficiency
Ind-Swift Laboratories Limited cash flow conversion efficiency. Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ind-Swift Laboratories Limited (2006–2025)
Cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View INDSWFTLAB share price today for real-time trading data and today's change.
Ind-Swift Laboratories Limited Cash Flow Conversion Ratio Explained
Ind-Swift Laboratories Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency. Also see Ind-Swift Laboratories Limited market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
|
0.006x |
|
Refex Industries Limited
NSE:REFEX
|
0.049x |
|
Xiamen Goldenhome Co Ltd
SHG:603180
|
-0.078x |
|
Five Point Holdings LLC
NYSE:FPH
|
-0.004x |
|
Norske Skog Asa
OL:NSKOG
|
-0.052x |
|
Digiworld Corp
VN:DGW
|
0.215x |
|
Hangzhou Coco Healthcare Products Co.Ltd.
SHE:301009
|
-0.012x |
|
Beijing Sanfo Outdoor Products Co Ltd
SHE:002780
|
-0.026x |
Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. Review Ind-Swift Laboratories Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs11.73 Billion ≈ $126.85 Million |
Rs-254.74 Million ≈ $-2.75 Million |
-0.022x | +89.19% |
| 2024-03-31 | Rs8.12 Billion ≈ $87.82 Million |
Rs-1.63 Billion ≈ $-17.64 Million |
-0.201x | -170.38% |
| 2023-03-31 | Rs6.82 Billion ≈ $73.75 Million |
Rs1.95 Billion ≈ $21.05 Million |
0.285x | +14.11% |
| 2022-03-31 | Rs6.01 Billion ≈ $64.98 Million |
Rs1.50 Billion ≈ $16.25 Million |
0.250x | +11.83% |
| 2021-03-31 | Rs6.03 Billion ≈ $65.26 Million |
Rs1.35 Billion ≈ $14.59 Million |
0.224x | +14.40% |
| 2020-03-31 | Rs6.41 Billion ≈ $69.28 Million |
Rs1.25 Billion ≈ $13.54 Million |
0.195x | +278.44% |
| 2019-03-31 | Rs5.88 Billion ≈ $63.57 Million |
Rs-644.00 Million ≈ $-6.96 Million |
-0.110x | -182.93% |
| 2018-03-31 | Rs5.53 Billion ≈ $59.83 Million |
Rs730.90 Million ≈ $7.90 Million |
0.132x | -26.55% |
| 2017-03-31 | Rs5.31 Billion ≈ $57.46 Million |
Rs955.66 Million ≈ $10.34 Million |
0.180x | +17.17% |
| 2016-03-31 | Rs5.17 Billion ≈ $55.96 Million |
Rs794.30 Million ≈ $8.59 Million |
0.154x | -7.25% |
| 2015-03-31 | Rs5.95 Billion ≈ $64.30 Million |
Rs983.98 Million ≈ $10.64 Million |
0.166x | +83.17% |
| 2014-03-31 | Rs7.25 Billion ≈ $78.43 Million |
Rs655.29 Million ≈ $7.09 Million |
0.090x | +265.47% |
| 2013-03-31 | Rs8.53 Billion ≈ $92.30 Million |
Rs-466.03 Million ≈ $-5.04 Million |
-0.055x | -161.11% |
| 2012-03-31 | Rs8.12 Billion ≈ $87.78 Million |
Rs725.24 Million ≈ $7.84 Million |
0.089x | +193.19% |
| 2011-03-31 | Rs5.84 Billion ≈ $63.10 Million |
Rs177.83 Million ≈ $1.92 Million |
0.030x | -69.08% |
| 2010-03-31 | Rs4.48 Billion ≈ $48.48 Million |
Rs441.84 Million ≈ $4.78 Million |
0.099x | -64.25% |
| 2009-03-31 | Rs3.63 Billion ≈ $39.27 Million |
Rs1.00 Billion ≈ $10.83 Million |
0.276x | +61.91% |
| 2008-03-31 | Rs3.33 Billion ≈ $36.06 Million |
Rs567.77 Million ≈ $6.14 Million |
0.170x | +17.18% |
| 2007-03-31 | Rs3.11 Billion ≈ $33.68 Million |
Rs452.62 Million ≈ $4.89 Million |
0.145x | +137.58% |
| 2006-03-31 | Rs1.92 Billion ≈ $20.80 Million |
Rs117.63 Million ≈ $1.27 Million |
0.061x | -- |
About Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hy… Read more